Martine Rothblatt
2013
In 2013, Martine Rothblatt earned a total compensation of $38.2M as Chairman and Co-Chief Executive Officer at United Therapeutics, a 380% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,102,907 |
|---|---|
| Option Awards | $36,097,326 |
| Salary | $992,678 |
| Other | $25,344 |
| Total | $38,218,255 |
Rothblatt received $36.1M in option awards, accounting for 94% of the total pay in 2013.
Rothblatt also received $1.1M in non-equity incentive plan, $992.7K in salary and $25.3K in other compensation.
Rankings
In 2013, Martine Rothblatt's compensation ranked 20th out of 12,286 executives tracked by ExecPay. In other words, Rothblatt earned more than 99.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 20 out of 12,286 | 100th |
Division Manufacturing | 4 out of 4,614 | 100th |
Major group Chemicals And Allied Products | 1 out of 1,466 | 100th |
Industry group Drugs | 1 out of 1,160 | 100th |
Industry Pharmaceutical Preparations | 1 out of 890 | 100th |
Source: SEC filing on April 28, 2016.
Rothblatt's colleagues
We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2013.